128 related articles for article (PubMed ID: 16995571)
1. Characterization of alterations in carbohydrate metabolism in children with Prader-Willi syndrome.
Krochik AG; Ozuna B; Torrado M; Chertkoff L; Mazza C
J Pediatr Endocrinol Metab; 2006 Jul; 19(7):911-8. PubMed ID: 16995571
[TBL] [Abstract][Full Text] [Related]
2. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
Crinò A; Di Giorgio G; Manco M; Grugni G; Maggioni A
Horm Res; 2007; 68(2):83-90. PubMed ID: 17337902
[TBL] [Abstract][Full Text] [Related]
3. Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects.
Schuster DP; Osei K; Zipf WB
Metabolism; 1996 Dec; 45(12):1514-20. PubMed ID: 8969285
[TBL] [Abstract][Full Text] [Related]
4. [Changes in carbohydrate metabolism and insulin resistance in patients with Prader-Willi Syndrome (PWS) under growth hormone therapy].
Lämmer C; Weimann E
Wien Med Wochenschr; 2007 Feb; 157(3-4):82-8. PubMed ID: 17340066
[TBL] [Abstract][Full Text] [Related]
5. Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome.
L'Allemand D; Eiholzer U; Schlumpf M; Torresani T; Girard J
Horm Res; 2003; 59(5):239-48. PubMed ID: 12714788
[TBL] [Abstract][Full Text] [Related]
6. Update on Diabetes Mellitus and Glucose Metabolism Alterations in Prader-Willi Syndrome.
Crinò A; Grugni G
Curr Diab Rep; 2020 Feb; 20(2):7. PubMed ID: 32030506
[TBL] [Abstract][Full Text] [Related]
7. Correlation of adiponectin receptor expression with cytokines and insulin sensitivity in growth hormone (GH)-treated children with Prader-Willi syndrome and in non-GH-treated obese children.
Sohn YB; Kwak MJ; Kim SJ; Park SW; Kim CH; Kim MY; Kwon EK; Paik KH; Jin DK
J Clin Endocrinol Metab; 2010 Mar; 95(3):1371-7. PubMed ID: 20061428
[TBL] [Abstract][Full Text] [Related]
8. Circulating Irisin in Children and Adolescents With Prader-Willi Syndrome: Relation With Glucose Metabolism.
Mai S; Fintini D; Mele C; Convertino A; Bocchini S; Grugni G; Aimaretti G; Vietti R; Scacchi M; Crinò A; Marzullo P
Front Endocrinol (Lausanne); 2022; 13():918467. PubMed ID: 35774143
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects.
Talebizadeh Z; Butler MG
Clin Genet; 2005 Mar; 67(3):230-9. PubMed ID: 15691361
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience.
Yang A; Kim J; Cho SY; Jin DK
Orphanet J Rare Dis; 2017 Aug; 12(1):146. PubMed ID: 28854950
[TBL] [Abstract][Full Text] [Related]
11. Glucose homeostasis in adults with Prader-Willi syndrome during treatment with growth hormone: results from a 12-month prospective study.
Jørgensen AP; Ueland T; Sode-Carlsen R; Schreiner T; Rabben KF; Farholt S; Høybye C; Christiansen JS; Bollerslev J
Growth Horm IGF Res; 2014 Feb; 24(1):16-21. PubMed ID: 24360789
[TBL] [Abstract][Full Text] [Related]
12. Suppression of acylated ghrelin during oral glucose tolerance test is correlated with whole-body insulin sensitivity in children with Prader-Willi syndrome.
Paik KH; Choe YH; Park WH; Oh YJ; Kim AH; Chu SH; Kim SW; Kwon EK; Han SJ; Shon WY; Jin DK
J Clin Endocrinol Metab; 2006 May; 91(5):1876-81. PubMed ID: 16507634
[TBL] [Abstract][Full Text] [Related]
13. Adrenarche in Prader-Willi syndrome appears not related to insulin sensitivity and serum adiponectin.
Unanue N; Bazaes R; Iñiguez G; Cortés F; Avila A; Mericq V
Horm Res; 2007; 67(3):152-8. PubMed ID: 17085944
[TBL] [Abstract][Full Text] [Related]
14. Postprandial metabolism in adults with Prader-Willi syndrome.
Purtell L; Viardot A; Sze L; Loughnan G; Steinbeck K; Sainsbury A; Herzog H; Smith A; Campbell LV
Obesity (Silver Spring); 2015 Jun; 23(6):1159-65. PubMed ID: 25958986
[TBL] [Abstract][Full Text] [Related]
15. Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones.
Haqq AM; Muehlbauer M; Svetkey LP; Newgard CB; Purnell JQ; Grambow SC; Freemark MS
Clin Endocrinol (Oxf); 2007 Dec; 67(6):944-51. PubMed ID: 17666087
[TBL] [Abstract][Full Text] [Related]
16. The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index.
Haqq AM; Muehlbauer MJ; Newgard CB; Grambow S; Freemark M
J Clin Endocrinol Metab; 2011 Jan; 96(1):E225-32. PubMed ID: 20962018
[TBL] [Abstract][Full Text] [Related]
17. Disorders of glucose metabolism in Prader-Willi syndrome: Results of a multicenter Italian cohort study.
Fintini D; Grugni G; Bocchini S; Brufani C; Di Candia S; Corrias A; Delvecchio M; Salvatoni A; Ragusa L; Greggio N; Franzese A; Scarano E; Trifirò G; Mazzanti L; Chiumello G; Cappa M; Crinò A;
Nutr Metab Cardiovasc Dis; 2016 Sep; 26(9):842-7. PubMed ID: 27381990
[TBL] [Abstract][Full Text] [Related]
18. Glucose homeostasis in Prader-Willi syndrome and potential implications of growth hormone therapy.
Zipf WB
Acta Paediatr Suppl; 1999 Dec; 88(433):115-7. PubMed ID: 10626560
[TBL] [Abstract][Full Text] [Related]
19. Do patients with Prader-Willi syndrome have favorable glucose metabolism?
Qian Y; Xia F; Zuo Y; Zhong M; Yang L; Jiang Y; Zou C
Orphanet J Rare Dis; 2022 May; 17(1):187. PubMed ID: 35525976
[TBL] [Abstract][Full Text] [Related]
20. The effect of growth hormone on the response of total and acylated ghrelin to a standardized oral glucose load and insulin resistance in children with Prader-Willi syndrome.
Hauffa BP; Haase K; Range IM; Unger N; Mann K; Petersenn S
J Clin Endocrinol Metab; 2007 Mar; 92(3):834-40. PubMed ID: 17192298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
